Triple cytokine fluorospot analysis of human antigen-specific IFN-γ, IL-17A and IL-22 responses

Cells

Volumn 3, Issue 4, 2014, Pages 1116-1130

  Dillenbeck, Tomas ^a   Gelius, Eva ^a   Foblstedt, Jenny ^a   Ahlborg, Niklas ^a,b  

^a Mabtech AB   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

ELISpot; FluoroSpot; IFN ; IL 17A; IL 22; T helper cell subsets; Th1; Th17; Th22

Indexed keywords

CANDIDA ALBICANS EXTRACT; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; TETANUS TOXOID; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ARTICLE; CELL ACTIVATION; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; IMMUNOSTIMULATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TH1 CELL; TH17 CELL; TH22 CELL; TRIPLE CYTOKINE FLUOROSPOT ANALYSIS;

CANDIDA ALBICANS;

EID: 85056746526     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3041116     Document Type: Article

References (29)

1. Mosmann, T.R.; Coffman, R.L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7, 145–173.
2. Miossec, P.; Korn, T.; Kuchroo, V.K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 2009, 361, 888–898.
3. Duhen, T.; Geiger, R.; Jarrossay, D.; Lanzavecchia, A.; Sallusto, F. Production of interleukin 22 but not Interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10, 857–863.
4. Mosmann, T.R.; Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today1996, 17, 138–146.
5. Ma, C.S.; Chew, G.Y.; Simpson, N.; Priyadarshi, A.; Wong, M.; Grimbacher, B.; Fulcher, D.A.; Tangye, S.G.; Cook, M.C. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in stat3. J. Exp. Med. 2008, 205, 1551–1557.
6. Puel, A.; Cypowyj, S.; Bustamante, J.; Wright, J.F.; Liu, L.; Lim, H.K.; Migaud, M.; Israel, L.; Chrabieh, M.; Audry, M.; et al. Chronic mucocutaneous candidiasis in humans with inborn errors of Interleukin-17 immunity. Science 2011, 332, 65–68.
7. Zheng, Y.; Valdez, P.A.; Danilenko, D.M.; Hu, Y.; Sa, S.M.; Gong, Q.; Abbas, A.R.; Modrusan, Z.; Ghilardi, N.; de Sauvage, F.J.; et al.Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14, 282–289.
8. Jager, A.; Kuchroo, V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 2010, 72, 173–184.
9. Bedoya, S.K.; Lam, B.; Lau, K.; Larkin, J., 3rd. Th17 cells in immunity and autoimmunity. Clin. Dev. Immunol. 2013, 2013, doi:10.1136/ard.2008.098004.
10. Langrish, C.L.; Chen, Y.; Blumenschein, W.M.; Mattson, J.; Basham, B.; Sedgwick, J.D.; McClanahan, T.; Kastelein, R.A.; Cua, D.J. IL-23 drives a pathogenic t cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201, 233–240.
11. Dyring-Andersen, B.; Skov, L.; Lovendorf, M.B.; Bzorek, M.; Sondergaard, K.; Lauritsen, J.P.; Dabelsteen, S.; Geisler, C.; Bonefeld, C.M. CD4(+) T cells producing Interleukin (IL)-17, IL-22 and Interferon-gamma are major effector T cells in nickel allergy. Contact Dermatitis2013, 68, 339–347.
12. Kagami, S.; Rizzo, H.L.; Lee, J.J.; Koguchi, Y.; Blauvelt, A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 2010, 130, 1373–1383.
13. Zheng, Y.; Danilenko, D.M.; Valdez, P.; Kasman, I.; Eastham-Anderson, J.; Wu, J.; Ouyang, W. Interleukin-22, a T(h)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature2007, 445, 648–651.
14. Boulet, S.; Ndongala, M.L.; Peretz, Y.; Boisvert, M.P.; Boulassel, M.R.; Tremblay, C.; Routy, J.P.; Sekaly, R.P.; Bernard, N.F. A dual color Elispot method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J. Immunol. Method. 2007, 320, 18–29.
15. Okamoto, Y.; Abe, T.; Niwa, T.; Mizuhashi, S.; Nishida, M. Development of a dual color enzyme-linked immunospot assay for simultaneous detection of murine T helper type 1- and T helper type 2-cells. Immunopharmacology1998, 39, 107–116.
16. Gazagne, A.; Claret, E.; Wijdenes, J.; Yssel, H.; Bousquet, F.; Levy, E.; Vielh, P.; Scotte, F.; Goupil, T.L.; Fridman W.H.; et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J. Immunol. Method. 2003, 283, 91–98.
17. Rebhahn, J.A.; Bishop, C.; Divekar, A.A.; Jiminez-Garcia, K.; Kobie, J.J.; Lee, F.E.; Maupin, G.M.; Snyder-Cappione, J.E.; Zaiss, D.M.; Mosmann, T.R. Automated analysis of two- and three-color fluorescent Elispot (Fluorospot) assays for cytokine secretion. Comput. Method. Program. Biomed. 2008, 92, 54–65.
18. Janetzki, S.; Rueger, M.; Dillenbeck, T. Stepping up ELISpot: Multi-level analysis in FluoroSpot assays. Cells, 2014, 3, 1102–1115.
19. Bayes, H.K.; Bicknell, S.; MacGregor, G.; Evans, T.J. T helper cell subsets specific for pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis. PLoS One 2014, 9, e90263.
20. Lenarczyk, A.; Helsloot, J.; Farmer, K.; Peters, L.; Sturgess, A.; Kirkham, B. Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin. Exp. Immunol. 2000, 122, 41–48.
21. Scriba, T.J.; Kalsdorf, B.; Abrahams, D.A.; Isaacs, F.; Hofmeister, J.; Black, G.; Hassan, H.Y.; Wilkinson, R.J.; Walzl, G.; Gelderbloem S.J.; et al. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 2008, 180, 1962–1970.
22. Smedman, C.; Ernemar, T.; Gudmundsdotter, L.; Gille-Johnson, P.; Somell, A.; Nihlmark, K.; Gardlund, B.; Andersson, J.; Paulie, S. Fluorospot analysis of TLR-activated monocytes reveals several distinct cytokine secreting subpopulations. Scand. J. Immunol. 2011.
23. Kesa, G.; Larsson, P.H.; Ahlborg, N.; Axelsson, B. Comparison of Elispot and Fluorospot in the analysis of swine flu-specific IgG and IgA secretion by in vivo activated human B cells. Cells2012, 1, 27–34.
24. Casey, R.; Blumenkrantz, D.; Millington, K.; Montamat-Sicotte, D.; Kon, O.M.; Wickremasinghe, M.; Bremang, S.; Magtoto, M.; Sridhar, S.; Connell D.; et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One2010, 5, e15619.
25. Sridhar, S.; Begom, S.; Bermingham, A.; Ziegler, T.; Roberts, K.L.; Barclay, W.S.; Openshaw, P.; Lalvani, A. Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults. Eur. J. Immunol. 2012, 42, 2913–2924.
26. Sunshine, J.; Kim, M.; Carlson, J.M.; Heckerman, D.; Czartoski, J.; Migueles, S.A.; Maenza, J.; McElrath, M.J.; Mullins, J.I.; Frahm, N. Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication. J. Virol. 2014, 88, 1354–1365.
27. Quast, S.; Zhang, W.; Shive, C.; Kovalovski, D.; Ott, P.A.; Herzog, B.A.; Boehm, B.O.; Tary-Lehmann, M.; Karulin, A.Y.; Lehmann, P.V. IL-2 absorption affects IFN-gamma and IL-5, but not IL-4 producing memory T cells in double color cytokine Elispot assays. Cell. Immunol. 2005, 237, 28–36.
28. Chauvat, A.; Benhamouda, N.; Gey, A.; Lemoine, F.M.; Paulie, S.; Carrat, F.; Gougeon, M.L.; Rozenberg, F.; Krivine, A.; Cherai M.; et al. Clinical validation of IFN-gamma/IL-10 and IFN-gamma/IL-2 Fluorospot assays for the detection of Tr1 t cells and influenza vaccine monitoring in humans. Hum. Vaccin. Immunother. 2014, 10, 104–113.
29. Pereyra, F.; Heckerman, D.; Carlson, J.M.; Kadie, C.; Soghoian, D.Z.; Karel, D.; Goldenthal, A.; Davis, O.B.; DeZiel, C.E.; Lin T.; et al.HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes. J. Virol. 2014, 88, 12937–12948.